Mark E Zafereo

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. Zafereo M. Surgical salvage of recurrent cancer of the head and neck. Curr Oncol Rep. 2014;16:386 pubmed publisher
  2. Tam S, Boonsripitayanon M, Amit M, Fellman B, Li Y, Busaidy N, et al. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions. Thyroid. 2018;: pubmed publisher
    ..Potential modifications that may improve disease-specific survival prediction in future renditions include reconsideration of T3b tumor category and upstaging classification of patients < 55 years of age with distant metastases. ..
  3. Gonçalves Filho J, Zafereo M, Ahmad F, Nixon I, Shaha A, Vander Poorten V, et al. Decision making for the central compartment in differentiated thyroid cancer. Eur J Surg Oncol. 2018;44:1671-1678 pubmed publisher
  4. Cabanillas M, Ferrarotto R, Garden A, Ahmed S, Busaidy N, Dadu R, et al. Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma. Thyroid. 2018;: pubmed publisher
    ..This novel neoadjuvant approach to BRAF-mutated ATC should be studied in further in clinical trials. ..
  5. Tam S, Amit M, Boonsripitayanon M, Busaidy N, Cabanillas M, Waguespack S, et al. The Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid. 2018;: pubmed publisher
    ..Group 3 [>4cm with mETE] HRadjusted=1.0, 95% CI=0.5-2.3). For LRF and DMF, size but not mETE was also an independent risk factor. Tumor size, and not the presence of mETE, was an independent predictor of DFS, LRF, and DMF in DTC. ..
  6. Amit M, Boonsripitayanon M, Goepfert R, Tam S, Busaidy N, Cabanillas M, et al. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol. 2018;25:3380-3388 pubmed publisher
    ..Although both gross strap muscle invasion and perithyroidal soft tissue extension may be predictive for locoregional recurrence, the distinction between them may not be as important for postoperative risk stratification. ..
  7. Maniakas A, Davies L, Zafereo M. Thyroid Disease Around the World. Otolaryngol Clin North Am. 2018;51:631-642 pubmed publisher
    ..Several of the most impactful epidemiologic studies are presented and analyzed, as well as a brief overview of the current socioeconomic burden of disease. ..
  8. Kansara S, Bell D, Johnson J, Zafereo M. Head and neck inflammatory pseudotumor: Case series and review of the literature. Neuroradiol J. 2016;29:440-446 pubmed
    ..Malignancy must be ruled out with incisional or excisional biopsy. Treatment includes surgical excision, oral corticosteroids, or both. The literature shows that radiotherapy and small-molecule inhibitors may be promising alternatives. ..
  9. Christakis I, Silva A, Williams M, Garden A, Grubbs E, Busaidy N, et al. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol. 2017;7:e463-e470 pubmed publisher
    ..XRT is well tolerated as postoperative locoregional treatment of patients with PC. Whether it is needed, and the timing of administering XRT, remains to be established. ..

More Information

Publications10

  1. Iyer P, Dadu R, Ferrarotto R, Busaidy N, Habra M, Zafereo M, et al. Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma. Thyroid. 2017;: pubmed publisher
    ..Patients with anaplastic thyroid cancer (ATC) have a dismal prognosis despite systemic cytotoxic chemotherapy. Our objective was to study the efficacy and safety of targeted therapy in ATC patients when used outside of a clinical trial...